Key facts
- It has raised $2.3M; the latest was Early Stage VC ($2.3M) in Jul 2025.
- Notable investors include Chemstars, IBG Beteiligungsgesellschaft Sachsen-Anhalt, Startup Elevator, TU Bergakademie Freiberg, Technologiegründerfonds Sachsen — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for CYNiO
- ·The full record, as it builds
Funding rounds
No funding rounds for CYNiO are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CYNiO
Developer of specialty chemical manufacturing processes designed for the sustainable production of isocyanates. The company offers a product that utilizes a proprietary synthesis method that replaces toxic phosgene with carbon dioxide, with enhanced safety, lower environmental impact, and adaptable small-batch production suited for innovation in chemical product development, enabling researchers and industrial developers in Europe to access a range of customizable isocyanate compounds
- Sector
- Materials and Resources
- HQ
- Bitterfeld-Wolfen, Germany
- Founded
- 2024
- Employees
- 9
- Website
- cynio.net/
- Ownership
- Privately Held (backing)
CYNiO doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CYNiO shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CYNiO in its N-PORT filings yet. We sweep new filings monthly.